-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Downgrades Haemonetics to Hold

Benzinga·12/15/2025 11:36:44
語音播報
Needham analyst Mike Matson downgrades Haemonetics (NYSE:HAE) from Buy to Hold.